[1] |
Mak P, Leav I, Pursell B, et al. ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading [J]. Cancer Cell,2010,17(4):319-332.
|
[2] |
Chen L,Qiu J, Yang C, et al. Identification of a novel estrogen receptor beta1 binding partner, inhibitor of differentiation-1 and role of ERbeta1 in human breast cancer cells [J]. Cancer Lett,2009,278(2):210-219.
|
[3] |
Kuiper GG, Enmark E, Pelto-Huikko M, et al. Cloning of a novel receptor expressed in rat prostate and ovary [J]. Proc Natl Acad Sci USA,1996;93(12):5925-5930.
|
[4] |
Honma N, Horii R, Iwase T, et al. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy [J]. J Clin Oncol,2008;26(22):3727-3734.
|
[5] |
Horimoto Y, Hartman J, Millour J, et al. ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer[J]. Am J Pathol,2011,179(3):1148-1156.
|
[6] |
周艳,姜军,杨新华,等. 他莫昔芬对转染ER β1 基因的MCF-7 细胞生长特性的影响[J/CD]. 中华乳腺病杂志:电子版,2008,2(1):63-69.
|
[7] |
Ye Y, Xiao Y, Wang W, et al.ERalpha signaling though slug regulates E-cadherin and EMT [J]. Oncogene, 2010,29(10):1451-1462.
|
[8] |
Park SH, Cheung LW, Wong AS, et al. Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha[J]. Mol Endocrinol, 2008,22(9):2085-2098.
|
[9] |
Goulioumis AK, Fuxe J, Varakis J, et al. Estrogen receptor-beta expression in human laryngeal carcinoma: correlation with the expression of epithelial-mesenchymal transition specific biomarkers[J]. Oncol Rep,2009,22(5):1063-1068.
|
[10] |
Ciarrocchi A, Piana S, Valcavi R, et al. Inhibitor of DNA binding-1 induces mesenchymal features and promotes invasiveness in thyroid tumour cells [J]. Eur J Cancer,2011,47(6):934-945.
|
[11] |
Li Y, Yang J, Luo JH, et al. Tubular epithelial cell dedifferentiation is driven by the helix-loop-helix transcriptional inhibitor Id1 [J]. J Am Soc Nephrol,2007,18(2):449-460.
|
[12] |
Gumireddy K, Li A, Gimotty PA, et al. KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer [J]. Nat Cell Biol,2009,11(11):1297-1304.
|